PepGen Inc. (PEPG) stock
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.04−0.22 (-4.18%)
Close on Nov 12, 2026Market cap $349.07MP/E –Yield –
PepGen EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
PepGen's EPS for the twelve months ending Sep 30, 2026 was -$1.07. For fiscal 2025 it was -$2.12. The highest annual figure on record is -$2.12 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.12 | – |
| FY2024 | Dec 31, 2024 | -$2.85 | – |
| FY2023 | Dec 31, 2023 | -$3.30 | – |
| FY2022 | Dec 31, 2022 | -$4.42 | – |
| FY2021 | Dec 31, 2021 | -$30.27 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.28 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.26 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.26 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.27 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.52 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.70 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.92 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.68 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.66 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.87 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.63 | – |
| Q4 FY2023 | Dec 31, 2023 | -$0.82 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.98 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.82 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.69 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.79 | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.23 | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.94 | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.75 | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.07 | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.03 | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.42 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?